Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

Not Applicable

Recruiting

Conditions: Squamous Cell Carcinoma

Interventions: Other: Standard surveillance
Other: Telemedicine surveillance (tele-surveillance)
Other: Questionnaires

First Posted Date: 2021-09-17

Last Posted Date: 2024-02-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT05048459

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers

Phase 1

Conditions: Healthy Volunteers

Interventions: Drug: Hyperpolarized [13C] Pyruvate

First Posted Date: 2021-09-10

Last Posted Date: 2024-09-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05041166

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

Not Applicable

Active, not recruiting

Conditions: Metastatic Cancer

Interventions: Radiation: Preoperative Stereotactic Body Radiotherapy (SBRT)

First Posted Date: 2021-09-08

Last Posted Date: 2024-04-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT05038124

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 4 locations

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Recruiting

Conditions: HER2-positive Breast Cancer
Breast Cancer Stage IV
Cardiotoxicity
HER2-positive Metastatic Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III
Breast Cancer
Breast Cancer Stage I

Interventions: Diagnostic Test: Cardiopulmonary Exercise Test
Diagnostic Test: Echocardiogram
Diagnostic Test: Echocardiography

First Posted Date: 2021-09-05

Last Posted Date: 2023-09-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT05036252

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

Phase 2

Active, not recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia

Interventions: Drug: E7820

First Posted Date: 2021-08-27

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT05024994

Locations: 🇺🇸
University of Miami (Data Collection AND Specimen Analysis Only), Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 4 locations

Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Other: BREAST-Q Reconstruction Module
Other: interactive 3D tool
Other: DQI
Other: Ottawa Decision Regret Scale

First Posted Date: 2021-08-27

Last Posted Date: 2023-09-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT05025020

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Phase 1

Active, not recruiting

Conditions: T-cell Lymphomas
NK-Cell Lymphomas
T-cell Prolymphocytic Leukemia
T-cell Large Granular Lymphocyte Leukemia

Interventions: Drug: Ruxolitinib
Drug: Duvelisib

First Posted Date: 2021-08-18

Last Posted Date: 2024-08-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 49

Registration Number: NCT05010005

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
University of Miami (Data Collection Only), Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 6 locations

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

Phase 2

Recruiting

Conditions: Metastatic Cancer

Interventions: Radiation: Palliative radiotherapy

First Posted Date: 2021-08-18

Last Posted Date: 2024-06-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT05010031

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

and more 4 locations

A Study of Repotrectinib in Combination with Chemotherapy in Children and Young Adults with Solid Tumor Cancer

Phase 1

Recruiting

Conditions: Advanced Cancer
Metastatic Solid Tumor

Interventions: Drug: Repotrectinib
Drug: Irinotecan and temozolomide

First Posted Date: 2021-08-13

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05004116

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2021-08-09

Last Posted Date: 2024-11-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 91

Registration Number: NCT04997018

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Victoria Brennan, Uniondale, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy